Regulatory B cells: Evidence, developmental origin and population diversity

Molecular Immunology

Volumn 48, Issue 1-3, 2010, Pages 1-8

  Vitale, Gaetano ^a   Mion, Francesca ^a   Pucillo, Carlo ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

B cells; Br1; Breg; IL 10; Immunoregulation; Regulatory B cells; Regulatory cells; Suppression

Indexed keywords

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CELL POPULATION; CYTOKINE RELEASE; IMMUNE RESPONSE; ONTOGENY; PRIORITY JOURNAL; REVIEW;

ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION;

EID: 78649499723     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.09.010     Document Type: Review

References (62)

1. Ahangarani R.R., Janssens W., Vanderelst L., Carlier V., Vandendriessche T., Chuah M., Weynand B., Vanoirbeek J.A., Jacquemin M., Saint-Remy J. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness. J. Immunol. 2009, 183:8232-8243.
2. Amu S., Saunders S.P., Kronenberg M., Mangan N.E., Atzberger A., Fallon P.G. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 2010, 125. 1114-1124.e8.
3. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002, 347:911-920.
4. Blair P.A., Chavez-Rueda K.A., Evans J.G., Shlomchik M.J., Eddaoudi A., Isenberg D.A., Ehrenstein M.R., Mauri C. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 2009, 182:3492-3502.
5. Blair P.A., Noreña L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
6. Castigli E., Alt F.W., Davidson L., Bottaro A., Mizoguchi E., Bhan A.K., Geha R.S. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12135-12139.
7. Correale J., Farez M. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J. Immunol. 2009, 183:5999-6012.
8. Correale J., Farez M., Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann. Neurol. 2008, 64:187-199.
9. DiLillo D.J., Matsushita T., Tedder T.F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 2010, 1183:38-57.
10. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., Mauri C. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 2007, 178:7868-7878.
11. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
12. Gerth A., Lin L., Neurath M., Glimcher L., Peng S. An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells* 1. Gastroenterology 2004, 126:1115-1121.
13. Gilbert K.M., Dresser D.W. Generation in vivo of non-T suppressor cells with the use of anti-allotype antibody. J. Immunol. 1988, 140:15-20.
14. Gillan V., Lawrence R.A., Devaney E. B cells play a regulatory role in mice infected with the L3 of Brugia pahangi. Int. Immunol. 2005, 17:373-382.
15. Gray D., Gray M., Barr T. Innate responses of B cells. Eur. J. Immunol. 2007, 37:3304-3310.
16. Gray M., Miles K., Salter D., Gray D., Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14080-14085.
17. Hardy R.R., Hayakawa K. B cell development pathways. Annu. Rev. Immunol. 2001, 19:595-621.
18. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., Johnson L.L., Swain S.L., Lund F.E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 2000, 1:475-482.
19. Jankovic D., Cheever A.W., Kullberg M.C., Wynn T.A., Yap G., Caspar P., Lewis F.A., Clynes R., Ravetch J.V., Sher A. CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J. Exp. Med. 1998, 187:619-629.
20. Kala M., Rhodes S.N., Piao W.H., Shi F.D., Campagnolo D.I., Vollmer T.L. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp. Neurol. 2010, 221:136-145.
21. Katz S.I., Parker D., Turk J.L. B-cell suppression of delayed hypersensitivity reactions. Nature 1974, 251:550-551.
22. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426.
23. Knoechel B., Lohr J., Kahn E., Abbas A.K. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J. Immunol. 2005, 175:21-26.
24. Kurosaki T. Paradox of B cell-targeted therapies. J. Clin. Invest. 2008, 118:3260-3263.
25. Lampropoulou V., Calderon-Gomez E., Roch T., Neves P., Shen P., Stervbo U., Boudinot P., Anderton S.M., Fillatreau S. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol. Rev. 2010, 233:146-161.
26. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderón Gómez E., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., Fillatreau S. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008, 180:4763-4773.
27. Lemoine S., Morva A., Youinou P., Jamin C. Regulatory B cells in autoimmune diseases: how do they work?. Ann N. Y. Acad. Sci. 2009, 1173:260-267.
28. Lenert P., Brummel R., Field E.H., Ashman R.F. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J. Clin. Immunol. 2005, 25:29-40.
29. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat. Rev. Immunol. 2010, 10:236-247.
30. Lundy S.K., Fox D.A. Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. Arthritis Res. Ther. 2009, 11:R128.
31. Mangan N.E., Fallon R.E., Smith P., van Rooijen N., McKenzie A.N., Fallon P.G. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J. Immunol. 2004, 173:6346-6356.
32. Mann M.K., Maresz K., Shriver L.P., Tan Y., Dittel B.N. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:3447-3456.
33. Matsushita T., Horikawa M., Iwata Y. Regulatory B Cells (B10 Cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase. J. Immunol. 2010, 185:2240-2252.
34. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008, 118:3420-3430.
35. Mauri C., Ehrenstein M.R. Cells of the synovium in rheumatoid arthritis. B cells. Arthritis Res. Ther. 2007, 9:205.
36. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 2003, 197:489.
37. Mizoguchi A., Bhan A.K. A case for regulatory B cells. J. Immunol. 2006, 176:705-710.
38. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16:219-230.
39. Mosser D.M., Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol. Rev. 2008, 226:205-218.
40. Neta R., Salvin S.B. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J. Immunol. 1974, 113:1716-1725.
41. Rafei M., Hsieh J., Zehntner S., Li M., Forner K., Birman E., Boivin M.N., Young Y.K., Perreault C., Galipeau J. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat. Med. 2009, 15:1038-1045.
42. Rafei M., Wu J.H., Annabi B., Lejeune L., François M., Galipeau J. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex. Blood 2007, 109:2234-2242.
43. Rieger A., Bar-Or A. B-cell-derived interleukin-10 in autoimmune disease: regulating the regulators. Nat. Rev. Immunol. 2008, 8:486-487.
44. Rolink A.G., Tschopp J., Schneider P., Melchers F. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 2002, 32:2004-2010.
45. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006, 212:28-50.
46. Ronet C., Hauyon-La Torre Y., Revaz-Breton M., Mastelic B., Tacchini-Cottier F., Louis J., Launois P. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J. Immunol. 2010, 184:886-894.
47. Ryan J.J., Gress R.E., Hathcock K.S., Hodes R.J. Recognition and response to alloantigens in vivo. II. Priming with accessory cell-depleted donor allogeneic splenocytes: induction of specific unresponsiveness to foreign major histocompatibility complex determinants. J. Immunol. 1984, 133:2343-2350.
48. Sagaert X., De Wolf-Peeters C. Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage. Immunol. Lett. 2003, 90:179-186.
49. Sun J.B., Flach C.F., Czerkinsky C., Holmgren J. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 2008, 181:8278-8287.
50. Takemori T., Rajewsky K. Specificity, duration and mechanism of idiotype suppression induced by neonatal injection of monoclonal anti-idiotope antibodies into mice. Eur. J. Immunol. 1984, 14:656-667.
51. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
52. Tian J., Zekzer D., Hanssen L., Lu Y., Olcott A., Kaufman D.L. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 2001, 167:1081-1089.
53. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003, 19:837-847.
54. Wilson M.S., Taylor M.D., O'Gorman M.T., Balic A., Barr T.A., Filbey K., Anderton S.M., Maizels R.M. Helminth-induced CD19(+)CD23(hi) B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 2010, 40:1682-1696.
55. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A.J. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996, 184:2271-2278.
56. Wong S.C., Puaux A.L., Chittezhath M., Shalova I., Kajiji T.S., Wang X., Abastado J.P., Biswas S.K. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol. 2010, 40:2296-2307.
57. Watanabe R., Ishiura N., Nakashima H., Kuwano Y., Okochi H., Tamaki K., Sato S., Tedder T.F., Fujimoto M. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 2010, 184:4801-4809.
58. Yanaba K., Bouaziz J.D., Matsushita T., Tsubata T., Tedder T.F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 2009, 182:7459-7472.
59. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
60. Yang M., Sun L., Wang S., Ko K.H., Xu H., Zheng B.J., Cao X., Lu L. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 2010, 184:3321-3325.
61. Zhang X., Deriaud E., Jiao X., Braun D., Leclerc C., Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J. Exp. Med. 2007, 204:1107-1118.
62. Zhao G., Moore D.J., Lee K.M., Kim J.I., Duff P.E., O'Connor M.R., Hirohashi T., Lei J., Yang M., Markmann J.F., Deng S. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am. J. Transplant 2010, 10:796-801.